What You Need To Know About Antibiotic-Resistant Gonorrhea

Why This STD Is Becoming More Difficult To Treat

Neisseria Gonorrhoeae
BSIP/UIG / Getty Images

Until recently, gonorrhea treatment was simply a matter of picking the right antibiotics. However, this is quickly ceasing to be the case. While gonorrhea is currently one of the most common treatable STDs in the United States, it may soon just be one of the most common STDs.

Why This Shift in Gonorrhea Statistics?

The number of gonorrhea cases resistant to treatment with antibiotics has continued to rise, and scientists are quickly running out of options.

Single-dose antibiotics for gonorrhea treatment are quickly becoming a thing of the past.

Gonorrhea, otherwise known as the clap, often seems like nothing more than a nuisance, particularly since it is so frequently asymptomatic, but that won't continue to be the case if we run out of antibiotics with which to treat it.

Left untreated, gonorrhea can lead to serious problems. It is, for example, a major cause of pelvic inflammatory disease and infertility. Gonorrhea can also lead to an infection known as disseminated gonorrhea, and cause problems in pregnant women and infants.

Because gonorrhea is so common, doctors would like to be able to treat it with a single, effective dose of medication. Single-dose gonorrhea antibiotics reduce problems with drug compliance that can increase the prevalence of antibiotic resistance, and also decrease the need for follow-up. Unfortunately, one-dose regimens may soon no longer be an option.

The affordable antibiotics that have been widely used to treat gonorrhea in the past are losing their effectiveness against a growing number of strains of this STD. Although it is still possible to find an antibiotic that can treat individual cases of gonorrhea, the choices are narrowing as multi-drug-resistant strains of the bacteria continue to appear.

At this point, American doctors have been recommended to stop giving oral antibiotics as a primary treatment and switch over to an injectable cocktail.

How Many Different Strains of Gonorrhea Exist?

The specific types of antibiotic-resistant gonorrhea strains seen in the U.S. and around the world vary from year to year, city to city, and population to population. Some scientists hope that by eliminating the use of gonorrhea antibiotics that are becoming ineffective, strains that are resistant to those drugs will decrease in prevalence so that the drugs will become useful once again.

Scientists have to hope, because they are quickly running out of drugs. In late 2012, scientists reported that the last effective oral antibiotic used to treat gonorrhea had begun to fail. In a few years, gonorrhea treatment will cease to be a simple process. Kicking an infection may require course after course of antibiotics, followed by repeated testing to see which, if any, of the antibiotics have worked. At that point, your best option will be one that you also have right now -- consistently practicing safe sex to avoid getting infected in the first place.

Antibiotics That Are No Longer Recommended For Gonorrhea Treatment

  • Sulfonamides 
  • Penicillin 
  • Tetracycline 
  • Fluoroquinolones 
  • Oral Cephalosporins 

Antibiotics Currently Used to Treat Gonorrhea

Combination Treatment with Injectable Cephalosporins. As of August 2012, the recommended treatment for gonorrhea is one injection of 250 mg ceftriaxone. This is combined with either a single oral dose of 1 g azithromycin or a week of taking 100 mg oral doxycycline twice a day.

To date, few gonorrhea strains are resistant to both types of antibiotic. However, this may not be true forever.

There are alternate treatment regimens available for people allergic to ceftriaxone, but they require patients to return for a second test to make certain they have been cured.


Barry PM, Klausner JD. The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin Pharmacother. 2009 Mar;10(4):555-77.

Bauer HM, Mark KE, Samuel M, Wang SA, Weismuller P, Moore D, Gunn RA, Peter C, Vannier A, DeAugustine N, Klausner JD, Knapp JS, Bolan G. Prevalence of and associated risk factors for fluoroquinolone-resistant Neisseria gonorrhoeae in California, 2000-2003. Clin Infect Dis. 2005 Sep 15;41(6):795-803.

Centers for Disease Control and Prevention (CDC). Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral Cephalosporins No Longer a Recommended Treatment for Gonococcal Infections. MMWR Morb Mortal Wkly Rep. 2012 August 10, 61(31);590-594.

Centers for Disease Control and Prevention (CDC). Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep. 2007 Apr 13;56(14):332-6.

Chisholm SA, Neal TJ, Alawattegama AB, Birley HD, Howe RA, Ison CA. Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales. J Antimicrob Chemother. 2009 Aug;64(2):353-8.

Herchline TE, Inkrott BP. Resistance trends in Neisseria gonorrhoeae in southwestern Ohio. Sex Transm Dis. 2010 Feb;37(2):121-2.

Kirkcaldy, R.D. et al. (2013). Cephalosporin-Resistant Gonorrhea in North America. Journal of the American Medical Association. 309(2):185-187.

Levenson D. Increasing cases of drug-resistant gonorrhea prompt new CDC treatment recommendations for gay and bisexual men. Rep Med Guidel Outcomes Res. 2004 May 14;15(10):8-9.

Vernel-Pauillac F, Ratsima EH, Guillard B, Goursaud R, Lethezer C, Hem S, Merien F, Goarant C. Correlation between antibiotic susceptibilities and genotypes in Neisseria gonorrhoeae from different geographical origins: determinants monitoring by real-time PCR as a complementary tool for surveillance. Sex Transm Infect. 2010 Apr;86(2):106-11.

Wang SA, Harvey AB, Conner SM, Zaidi AA, Knapp JS, Whittington WL, del Rio C, Judson FN, Holmes KK. Antimicrobial resistance for Neisseria gonorrhoeae in the United States, 1988 to 2003: the spread of fluoroquinolone resistance. Ann Intern Med. 2007 Jul 17;147(2):81-8.